1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Phase
1.2.1 Global In Silico Clinical Trials Market Size Growth Rate by Phase: 2017 VS 2021 VS 2028
1.2.2 Phase I
1.2.3 Phase II
1.2.4 Phase III
1.2.5 Phase IV
1.3 Market by Application
1.3.1 Global In Silico Clinical Trials Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Infectious Disease
1.3.4 Hematology
1.3.5 Cardiology
1.3.6 Dermatology
1.3.7 Neurology
1.3.8 Diabetes
1.3.9 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global In Silico Clinical Trials Market Perspective (2017-2028)
2.2 In Silico Clinical Trials Growth Trends by Region
2.2.1 In Silico Clinical Trials Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 In Silico Clinical Trials Historic Market Size by Region (2017-2022)
2.2.3 In Silico Clinical Trials Forecasted Market Size by Region (2023-2028)
2.3 In Silico Clinical Trials Market Dynamics
2.3.1 In Silico Clinical Trials Industry Trends
2.3.2 In Silico Clinical Trials Market Drivers
2.3.3 In Silico Clinical Trials Market Challenges
2.3.4 In Silico Clinical Trials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Silico Clinical Trials Players by Revenue
3.1.1 Global Top In Silico Clinical Trials Players by Revenue (2017-2022)
3.1.2 Global In Silico Clinical Trials Revenue Market Share by Players (2017-2022)
3.2 Global In Silico Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In Silico Clinical Trials Revenue
3.4 Global In Silico Clinical Trials Market Concentration Ratio
3.4.1 Global In Silico Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Silico Clinical Trials Revenue in 2021
3.5 In Silico Clinical Trials Key Players Head office and Area Served
3.6 Key Players In Silico Clinical Trials Product Solution and Service
3.7 Date of Enter into In Silico Clinical Trials Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In Silico Clinical Trials Breakdown Data by Phase
4.1 Global In Silico Clinical Trials Historic Market Size by Phase (2017-2022)
4.2 Global In Silico Clinical Trials Forecasted Market Size by Phase (2023-2028)
5 In Silico Clinical Trials Breakdown Data by Application
5.1 Global In Silico Clinical Trials Historic Market Size by Application (2017-2022)
5.2 Global In Silico Clinical Trials Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America In Silico Clinical Trials Market Size (2017-2028)
6.2 North America In Silico Clinical Trials Market Size by Country (2017-2022)
6.3 North America In Silico Clinical Trials Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe In Silico Clinical Trials Market Size (2017-2028)
7.2 Europe In Silico Clinical Trials Market Size by Country (2017-2022)
7.3 Europe In Silico Clinical Trials Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Silico Clinical Trials Market Size (2017-2028)
8.2 Asia-Pacific In Silico Clinical Trials Market Size by Country (2017-2022)
8.3 Asia-Pacific In Silico Clinical Trials Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America In Silico Clinical Trials Market Size (2017-2028)
9.2 Latin America In Silico Clinical Trials Market Size by Country (2017-2022)
9.3 Latin America In Silico Clinical Trials Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Silico Clinical Trials Market Size (2017-2028)
10.2 Middle East & Africa In Silico Clinical Trials Market Size by Country (2017-2022)
10.3 Middle East & Africa In Silico Clinical Trials Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Certara, Inc.
11.1.1 Certara, Inc. Company Detail
11.1.2 Certara, Inc. Business Overview
11.1.3 Certara, Inc. In Silico Clinical Trials Introduction
11.1.4 Certara, Inc. Revenue in In Silico Clinical Trials Business (2017-2022)
11.1.5 Certara, Inc. Recent Development
11.2 Novadiscovery Sas
11.2.1 Novadiscovery Sas Company Detail
11.2.2 Novadiscovery Sas Business Overview
11.2.3 Novadiscovery Sas In Silico Clinical Trials Introduction
11.2.4 Novadiscovery Sas Revenue in In Silico Clinical Trials Business (2017-2022)
11.2.5 Novadiscovery Sas Recent Development
11.3 Insilico Medicine, Inc.
11.3.1 Insilico Medicine, Inc. Company Detail
11.3.2 Insilico Medicine, Inc. Business Overview
11.3.3 Insilico Medicine, Inc. In Silico Clinical Trials Introduction
11.3.4 Insilico Medicine, Inc. Revenue in In Silico Clinical Trials Business (2017-2022)
11.3.5 Insilico Medicine, Inc. Recent Development
11.4 Dassault Systemes SE
11.4.1 Dassault Systemes SE Company Detail
11.4.2 Dassault Systemes SE Business Overview
11.4.3 Dassault Systemes SE In Silico Clinical Trials Introduction
11.4.4 Dassault Systemes SE Revenue in In Silico Clinical Trials Business (2017-2022)
11.4.5 Dassault Systemes SE Recent Development
11.5 GNS Healthcare Inc.
11.5.1 GNS Healthcare Inc. Company Detail
11.5.2 GNS Healthcare Inc. Business Overview
11.5.3 GNS Healthcare Inc. In Silico Clinical Trials Introduction
11.5.4 GNS Healthcare Inc. Revenue in In Silico Clinical Trials Business (2017-2022)
11.5.5 GNS Healthcare Inc. Recent Development
11.6 The AnyLogic Company
11.6.1 The AnyLogic Company Company Detail
11.6.2 The AnyLogic Company Business Overview
11.6.3 The AnyLogic Company In Silico Clinical Trials Introduction
11.6.4 The AnyLogic Company Revenue in In Silico Clinical Trials Business (2017-2022)
11.6.5 The AnyLogic Company Recent Development
11.7 InSilicoTrials
11.7.1 InSilicoTrials Company Detail
11.7.2 InSilicoTrials Business Overview
11.7.3 InSilicoTrials In Silico Clinical Trials Introduction
11.7.4 InSilicoTrials Revenue in In Silico Clinical Trials Business (2017-2022)
11.7.5 InSilicoTrials Recent Development
11.8 Immunetrics Inc.
11.8.1 Immunetrics Inc. Company Detail
11.8.2 Immunetrics Inc. Business Overview
11.8.3 Immunetrics Inc. In Silico Clinical Trials Introduction
11.8.4 Immunetrics Inc. Revenue in In Silico Clinical Trials Business (2017-2022)
11.8.5 Immunetrics Inc. Recent Development
11.9 Nuventra Pharma Sciences
11.9.1 Nuventra Pharma Sciences Company Detail
11.9.2 Nuventra Pharma Sciences Business Overview
11.9.3 Nuventra Pharma Sciences In Silico Clinical Trials Introduction
11.9.4 Nuventra Pharma Sciences Revenue in In Silico Clinical Trials Business (2017-2022)
11.9.5 Nuventra Pharma Sciences Recent Development
11.10 Abzena Ltd.
11.10.1 Abzena Ltd. Company Detail
11.10.2 Abzena Ltd. Business Overview
11.10.3 Abzena Ltd. In Silico Clinical Trials Introduction
11.10.4 Abzena Ltd. Revenue in In Silico Clinical Trials Business (2017-2022)
11.10.5 Abzena Ltd. Recent Development
11.11 Siemens
11.11.1 Siemens Company Detail
11.11.2 Siemens Business Overview
11.11.3 Siemens In Silico Clinical Trials Introduction
11.11.4 Siemens Revenue in In Silico Clinical Trials Business (2017-2022)
11.11.5 Siemens Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global In Silico Clinical Trials Market Size Growth Rate by Phase (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Phase I
Table 3. Key Players of Phase II
Table 4. Key Players of Phase III
Table 5. Key Players of Phase IV
Table 6. Global In Silico Clinical Trials Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global In Silico Clinical Trials Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global In Silico Clinical Trials Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global In Silico Clinical Trials Market Share by Region (2017-2022)
Table 10. Global In Silico Clinical Trials Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global In Silico Clinical Trials Market Share by Region (2023-2028)
Table 12. In Silico Clinical Trials Market Trends
Table 13. In Silico Clinical Trials Market Drivers
Table 14. In Silico Clinical Trials Market Challenges
Table 15. In Silico Clinical Trials Market Restraints
Table 16. Global In Silico Clinical Trials Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global In Silico Clinical Trials Market Share by Players (2017-2022)
Table 18. Global Top In Silico Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Silico Clinical Trials as of 2021)
Table 19. Ranking of Global Top In Silico Clinical Trials Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by In Silico Clinical Trials Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players In Silico Clinical Trials Product Solution and Service
Table 23. Date of Enter into In Silico Clinical Trials Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global In Silico Clinical Trials Market Size by Phase (2017-2022) & (US$ Million)
Table 26. Global In Silico Clinical Trials Revenue Market Share by Phase (2017-2022)
Table 27. Global In Silico Clinical Trials Forecasted Market Size by Phase (2023-2028) & (US$ Million)
Table 28. Global In Silico Clinical Trials Revenue Market Share by Phase (2023-2028)
Table 29. Global In Silico Clinical Trials Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global In Silico Clinical Trials Revenue Market Share by Application (2017-2022)
Table 31. Global In Silico Clinical Trials Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global In Silico Clinical Trials Revenue Market Share by Application (2023-2028)
Table 33. North America In Silico Clinical Trials Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America In Silico Clinical Trials Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe In Silico Clinical Trials Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe In Silico Clinical Trials Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific In Silico Clinical Trials Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific In Silico Clinical Trials Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America In Silico Clinical Trials Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America In Silico Clinical Trials Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa In Silico Clinical Trials Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa In Silico Clinical Trials Market Size by Country (2023-2028) & (US$ Million)
Table 43. Certara, Inc. Company Detail
Table 44. Certara, Inc. Business Overview
Table 45. Certara, Inc. In Silico Clinical Trials Product
Table 46. Certara, Inc. Revenue in In Silico Clinical Trials Business (2017-2022) & (US$ Million)
Table 47. Certara, Inc. Recent Development
Table 48. Novadiscovery Sas Company Detail
Table 49. Novadiscovery Sas Business Overview
Table 50. Novadiscovery Sas In Silico Clinical Trials Product
Table 51. Novadiscovery Sas Revenue in In Silico Clinical Trials Business (2017-2022) & (US$ Million)
Table 52. Novadiscovery Sas Recent Development
Table 53. Insilico Medicine, Inc. Company Detail
Table 54. Insilico Medicine, Inc. Business Overview
Table 55. Insilico Medicine, Inc. In Silico Clinical Trials Product
Table 56. Insilico Medicine, Inc. Revenue in In Silico Clinical Trials Business (2017-2022) & (US$ Million)
Table 57. Insilico Medicine, Inc. Recent Development
Table 58. Dassault Systemes SE Company Detail
Table 59. Dassault Systemes SE Business Overview
Table 60. Dassault Systemes SE In Silico Clinical Trials Product
Table 61. Dassault Systemes SE Revenue in In Silico Clinical Trials Business (2017-2022) & (US$ Million)
Table 62. Dassault Systemes SE Recent Development
Table 63. GNS Healthcare Inc. Company Detail
Table 64. GNS Healthcare Inc. Business Overview
Table 65. GNS Healthcare Inc. In Silico Clinical Trials Product
Table 66. GNS Healthcare Inc. Revenue in In Silico Clinical Trials Business (2017-2022) & (US$ Million)
Table 67. GNS Healthcare Inc. Recent Development
Table 68. The AnyLogic Company Company Detail
Table 69. The AnyLogic Company Business Overview
Table 70. The AnyLogic Company In Silico Clinical Trials Product
Table 71. The AnyLogic Company Revenue in In Silico Clinical Trials Business (2017-2022) & (US$ Million)
Table 72. The AnyLogic Company Recent Development
Table 73. InSilicoTrials Company Detail
Table 74. InSilicoTrials Business Overview
Table 75. InSilicoTrials In Silico Clinical Trials Product
Table 76. InSilicoTrials Revenue in In Silico Clinical Trials Business (2017-2022) & (US$ Million)
Table 77. InSilicoTrials Recent Development
Table 78. Immunetrics Inc. Company Detail
Table 79. Immunetrics Inc. Business Overview
Table 80. Immunetrics Inc. In Silico Clinical Trials Product
Table 81. Immunetrics Inc. Revenue in In Silico Clinical Trials Business (2017-2022) & (US$ Million)
Table 82. Immunetrics Inc. Recent Development
Table 83. Nuventra Pharma Sciences Company Detail
Table 84. Nuventra Pharma Sciences Business Overview
Table 85. Nuventra Pharma Sciences In Silico Clinical Trials Product
Table 86. Nuventra Pharma Sciences Revenue in In Silico Clinical Trials Business (2017-2022) & (US$ Million)
Table 87. Nuventra Pharma Sciences Recent Development
Table 88. Abzena Ltd. Company Detail
Table 89. Abzena Ltd. Business Overview
Table 90. Abzena Ltd. In Silico Clinical Trials Product
Table 91. Abzena Ltd. Revenue in In Silico Clinical Trials Business (2017-2022) & (US$ Million)
Table 92. Abzena Ltd. Recent Development
Table 93. Siemens Company Detail
Table 94. Siemens Business Overview
Table 95. Siemens In Silico Clinical TrialsProduct
Table 96. Siemens Revenue in In Silico Clinical Trials Business (2017-2022) & (US$ Million)
Table 97. Siemens Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In Silico Clinical Trials Market Share by Phase: 2021 VS 2028
Figure 2. Phase I Features
Figure 3. Phase II Features
Figure 4. Phase III Features
Figure 5. Phase IV Features
Figure 6. Global In Silico Clinical Trials Market Share by Application in 2021 & 2028
Figure 7. Oncology Case Studies
Figure 8. Infectious Disease Case Studies
Figure 9. Hematology Case Studies
Figure 10. Cardiology Case Studies
Figure 11. Dermatology Case Studies
Figure 12. Neurology Case Studies
Figure 13. Diabetes Case Studies
Figure 14. Others Case Studies
Figure 15. In Silico Clinical Trials Report Years Considered
Figure 16. Global In Silico Clinical Trials Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 17. Global In Silico Clinical Trials Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global In Silico Clinical Trials Market Share by Region: 2021 VS 2028
Figure 19. Global In Silico Clinical Trials Market Share by Players in 2021
Figure 20. Global Top In Silico Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Silico Clinical Trials as of 2021)
Figure 21. The Top 10 and 5 Players Market Share by In Silico Clinical Trials Revenue in 2021
Figure 22. North America In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. North America In Silico Clinical Trials Market Share by Country (2017-2028)
Figure 24. United States In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Canada In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Europe In Silico Clinical Trials Market Share by Country (2017-2028)
Figure 28. Germany In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific In Silico Clinical Trials Market Share by Region (2017-2028)
Figure 36. China In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Latin America In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Latin America In Silico Clinical Trials Market Share by Country (2017-2028)
Figure 44. Mexico In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Brazil In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Middle East & Africa In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa In Silico Clinical Trials Market Share by Country (2017-2028)
Figure 48. Turkey In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Saudi Arabia In Silico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Certara, Inc. Revenue Growth Rate in In Silico Clinical Trials Business (2017-2022)
Figure 51. Novadiscovery Sas Revenue Growth Rate in In Silico Clinical Trials Business (2017-2022)
Figure 52. Insilico Medicine, Inc. Revenue Growth Rate in In Silico Clinical Trials Business (2017-2022)
Figure 53. Dassault Systemes SE Revenue Growth Rate in In Silico Clinical Trials Business (2017-2022)
Figure 54. GNS Healthcare Inc. Revenue Growth Rate in In Silico Clinical Trials Business (2017-2022)
Figure 55. The AnyLogic Company Revenue Growth Rate in In Silico Clinical Trials Business (2017-2022)
Figure 56. InSilicoTrials Revenue Growth Rate in In Silico Clinical Trials Business (2017-2022)
Figure 57. Immunetrics Inc. Revenue Growth Rate in In Silico Clinical Trials Business (2017-2022)
Figure 58. Nuventra Pharma Sciences Revenue Growth Rate in In Silico Clinical Trials Business (2017-2022)
Figure 59. Abzena Ltd. Revenue Growth Rate in In Silico Clinical Trials Business (2017-2022)
Figure 60. Siemens Revenue Growth Rate in In Silico Clinical Trials Business (2017-2022)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
